CHROMITOPE SODIUM
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Dec 1971
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 17h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CHROMITOPE SODIUM is a chromium-51 labeled diagnostic injectable approved in 1971, used for nuclear medicine imaging procedures. The product employs radioisotope labeling technology to enable visualization of physiological processes. It is a legacy diagnostic agent with established clinical utility in specific imaging applications.
LOE Approaching
This legacy diagnostic product faces approaching loss of exclusivity with minimal ongoing marketing investment, suggesting very small dedicated team and limited commercial expansion opportunities.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on CHROMITOPE SODIUM offers minimal career growth opportunity, as the product is a legacy diagnostic agent approaching loss of exclusivity with no linked job openings and limited commercial activity. Positions available would focus on compliance, manufacturing continuity, and regulatory maintenance rather than strategic growth or innovation.
Regulatory Affairs Specialist
Worked on CHROMITOPE SODIUM at Bracco? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.